SAGE Therapeutics's total assets for Q3 2024 were $622.43M, a decrease of -10.71% from the previous quarter. SAGE total liabilities were $70.60M for the fiscal quarter, a 2.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.